ClinicalTrials.Veeva

Menu

Adverse Drug Reactions of Different Brands of Ceftazidime Injection

National Taiwan University logo

National Taiwan University

Status and phase

Unknown
Phase 4

Conditions

Infection

Treatments

Drug: ceftazidime

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.

Full description

Ceftazidime is a third generation cephalosporins that should be reserved for severe bacterial infections. Substitution of the brand ceftazidime with a generic ceftazidime raised some concerns.

The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.

Sex

All

Ages

1 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients in surgical intensive care unit who require ceftazidime treatment

Exclusion criteria

  • less than 1 year old

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems